nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ORM1—Bupropion—obesity	0.212	0.521	CbGbCtD
Canagliflozin—ALB—obesity	0.181	1	CbGaD
Canagliflozin—CYP3A4—Sibutramine—obesity	0.0434	0.107	CbGbCtD
Canagliflozin—ABCB1—Cimetidine—obesity	0.0343	0.0841	CbGbCtD
Canagliflozin—CYP3A4—Benzphetamine—obesity	0.0329	0.0807	CbGbCtD
Canagliflozin—CYP3A4—Bupropion—obesity	0.028	0.0687	CbGbCtD
Canagliflozin—CYP3A4—Orlistat—obesity	0.0228	0.056	CbGbCtD
Canagliflozin—CYP3A4—Cimetidine—obesity	0.0205	0.0504	CbGbCtD
Canagliflozin—CYP3A4—Topiramate—obesity	0.0134	0.033	CbGbCtD
Canagliflozin—ORM1—bile—obesity	0.00929	0.147	CbGeAlD
Canagliflozin—ABCC2—bile—obesity	0.00764	0.121	CbGeAlD
Canagliflozin—Rash vesicular—Sibutramine—obesity	0.00644	0.0418	CcSEcCtD
Canagliflozin—SLC5A1—respiratory system—obesity	0.00482	0.0761	CbGeAlD
Canagliflozin—SLC5A1—cardiovascular system—obesity	0.00369	0.0583	CbGeAlD
Canagliflozin—UGT2B4—cardiovascular system—obesity	0.0034	0.0537	CbGeAlD
Canagliflozin—SLC5A2—endocrine gland—obesity	0.00334	0.0528	CbGeAlD
Canagliflozin—SLC5A1—pituitary gland—obesity	0.00327	0.0516	CbGeAlD
Canagliflozin—Sunburn—Bupropion—obesity	0.00322	0.0209	CcSEcCtD
Canagliflozin—Rash papular—Orlistat—obesity	0.0031	0.0201	CcSEcCtD
Canagliflozin—SLC5A1—digestive system—obesity	0.00307	0.0484	CbGeAlD
Canagliflozin—Rash macular—Sibutramine—obesity	0.00272	0.0177	CcSEcCtD
Canagliflozin—ORM1—gall bladder—obesity	0.00258	0.0407	CbGeAlD
Canagliflozin—UGT2B4—endocrine gland—obesity	0.00233	0.0369	CbGeAlD
Canagliflozin—ALB—gall bladder—obesity	0.00226	0.0357	CbGeAlD
Canagliflozin—Prurigo—Bupropion—obesity	0.00211	0.0137	CcSEcCtD
Canagliflozin—UGT2B4—liver—obesity	0.0021	0.0332	CbGeAlD
Canagliflozin—Polydipsia—Topiramate—obesity	0.002	0.013	CcSEcCtD
Canagliflozin—Urine output increased—Diethylpropion—obesity	0.00199	0.0129	CcSEcCtD
Canagliflozin—Fracture—Orlistat—obesity	0.00198	0.0129	CcSEcCtD
Canagliflozin—Multiple fractures—Orlistat—obesity	0.00198	0.0129	CcSEcCtD
Canagliflozin—UGT1A9—digestive system—obesity	0.00193	0.0305	CbGeAlD
Canagliflozin—Polyuria—Diethylpropion—obesity	0.00182	0.0118	CcSEcCtD
Canagliflozin—Pollakiuria—Phendimetrazine—obesity	0.00179	0.0116	CcSEcCtD
Canagliflozin—Vulvovaginal mycotic infection—Bupropion—obesity	0.00178	0.0116	CcSEcCtD
Canagliflozin—Dizziness postural—Topiramate—obesity	0.00177	0.0115	CcSEcCtD
Canagliflozin—Micturition urgency—Bupropion—obesity	0.00172	0.0111	CcSEcCtD
Canagliflozin—UGT1A9—endocrine gland—obesity	0.00159	0.0252	CbGeAlD
Canagliflozin—Rash macular—Topiramate—obesity	0.00151	0.00981	CcSEcCtD
Canagliflozin—UGT1A9—liver—obesity	0.00144	0.0227	CbGeAlD
Canagliflozin—Blood creatinine increased—Cimetidine—obesity	0.00142	0.00922	CcSEcCtD
Canagliflozin—Rash pustular—Sibutramine—obesity	0.0014	0.00909	CcSEcCtD
Canagliflozin—Pancreatitis—Cimetidine—obesity	0.00129	0.00834	CcSEcCtD
Canagliflozin—Rash erythematous—Bupropion—obesity	0.00127	0.00825	CcSEcCtD
Canagliflozin—Hyperkalaemia—Sibutramine—obesity	0.0011	0.00712	CcSEcCtD
Canagliflozin—Micturition urgency—Topiramate—obesity	0.00109	0.00709	CcSEcCtD
Canagliflozin—Cystitis noninfective—Sibutramine—obesity	0.00109	0.00708	CcSEcCtD
Canagliflozin—Vaginal infection—Orlistat—obesity	0.00109	0.00707	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Methamphetamine—obesity	0.00108	0.00703	CcSEcCtD
Canagliflozin—Cystitis—Sibutramine—obesity	0.00108	0.007	CcSEcCtD
Canagliflozin—Constipation—Methamphetamine—obesity	0.00107	0.00696	CcSEcCtD
Canagliflozin—Blood urea increased—Sibutramine—obesity	0.00105	0.00684	CcSEcCtD
Canagliflozin—Nocturia—Bupropion—obesity	0.00105	0.00681	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Benzphetamine—obesity	0.00104	0.00677	CcSEcCtD
Canagliflozin—Urine output increased—Orlistat—obesity	0.00104	0.00677	CcSEcCtD
Canagliflozin—Bladder pain—Sibutramine—obesity	0.00101	0.00655	CcSEcCtD
Canagliflozin—Urticaria—Methamphetamine—obesity	0.000996	0.00646	CcSEcCtD
Canagliflozin—Diabetes mellitus—Orlistat—obesity	0.000963	0.00625	CcSEcCtD
Canagliflozin—Urticaria—Benzphetamine—obesity	0.00096	0.00623	CcSEcCtD
Canagliflozin—Erythema—Diethylpropion—obesity	0.00096	0.00623	CcSEcCtD
Canagliflozin—Polyuria—Orlistat—obesity	0.000954	0.00619	CcSEcCtD
Canagliflozin—Cystitis noninfective—Bupropion—obesity	0.000951	0.00617	CcSEcCtD
Canagliflozin—Constipation—Phendimetrazine—obesity	0.000942	0.00612	CcSEcCtD
Canagliflozin—Cystitis—Bupropion—obesity	0.00094	0.0061	CcSEcCtD
Canagliflozin—Diabetes mellitus—Sibutramine—obesity	0.000932	0.00605	CcSEcCtD
Canagliflozin—Hypersensitivity—Methamphetamine—obesity	0.000924	0.006	CcSEcCtD
Canagliflozin—Photosensitivity—Sibutramine—obesity	0.000923	0.00599	CcSEcCtD
Canagliflozin—Vaginal infection—Bupropion—obesity	0.000919	0.00596	CcSEcCtD
Canagliflozin—Dry mouth—Phentermine—obesity	0.000919	0.00596	CcSEcCtD
Canagliflozin—Hypersensitivity—Benzphetamine—obesity	0.000891	0.00578	CcSEcCtD
Canagliflozin—Rash maculo-papular—Bupropion—obesity	0.000885	0.00574	CcSEcCtD
Canagliflozin—Bladder pain—Bupropion—obesity	0.00088	0.00571	CcSEcCtD
Canagliflozin—Urine output increased—Bupropion—obesity	0.00088	0.00571	CcSEcCtD
Canagliflozin—Thirst—Orlistat—obesity	0.00088	0.00571	CcSEcCtD
Canagliflozin—Hypotension—Phenylpropanolamine—obesity	0.000879	0.00571	CcSEcCtD
Canagliflozin—Abdominal pain—Phendimetrazine—obesity	0.000871	0.00565	CcSEcCtD
Canagliflozin—Hypoglycaemia—Orlistat—obesity	0.000858	0.00557	CcSEcCtD
Canagliflozin—Thirst—Sibutramine—obesity	0.000852	0.00553	CcSEcCtD
Canagliflozin—ALB—adrenal gland—obesity	0.000848	0.0134	CbGeAlD
Canagliflozin—ORM1—endocrine gland—obesity	0.000839	0.0132	CbGeAlD
Canagliflozin—ABCC2—digestive system—obesity	0.000834	0.0132	CbGeAlD
Canagliflozin—Convulsion—Diethylpropion—obesity	0.000832	0.0054	CcSEcCtD
Canagliflozin—Hypoglycaemia—Sibutramine—obesity	0.00083	0.00539	CcSEcCtD
Canagliflozin—Dizziness—Methamphetamine—obesity	0.000829	0.00538	CcSEcCtD
Canagliflozin—Rash erythematous—Topiramate—obesity	0.00081	0.00526	CcSEcCtD
Canagliflozin—Constipation—Phenylpropanolamine—obesity	0.000805	0.00522	CcSEcCtD
Canagliflozin—Photosensitivity—Bupropion—obesity	0.000805	0.00522	CcSEcCtD
Canagliflozin—Polyuria—Bupropion—obesity	0.000805	0.00522	CcSEcCtD
Canagliflozin—Dizziness—Benzphetamine—obesity	0.000799	0.00519	CcSEcCtD
Canagliflozin—Dry mouth—Diethylpropion—obesity	0.000799	0.00519	CcSEcCtD
Canagliflozin—ABCC2—adrenal gland—obesity	0.000795	0.0126	CbGeAlD
Canagliflozin—Gastrointestinal disorder—Phentermine—obesity	0.000778	0.00505	CcSEcCtD
Canagliflozin—Fatigue—Phentermine—obesity	0.000776	0.00504	CcSEcCtD
Canagliflozin—Constipation—Phentermine—obesity	0.00077	0.005	CcSEcCtD
Canagliflozin—Blood creatinine increased—Sibutramine—obesity	0.000759	0.00493	CcSEcCtD
Canagliflozin—Breast disorder—Orlistat—obesity	0.000757	0.00491	CcSEcCtD
Canagliflozin—ORM1—liver—obesity	0.000756	0.0119	CbGeAlD
Canagliflozin—Dehydration—Sibutramine—obesity	0.000754	0.00489	CcSEcCtD
Canagliflozin—Thirst—Bupropion—obesity	0.000742	0.00482	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Sibutramine—obesity	0.00074	0.0048	CcSEcCtD
Canagliflozin—Dizziness—Phendimetrazine—obesity	0.000729	0.00473	CcSEcCtD
Canagliflozin—Hypoglycaemia—Bupropion—obesity	0.000724	0.0047	CcSEcCtD
Canagliflozin—Nausea—Benzphetamine—obesity	0.000718	0.00466	CcSEcCtD
Canagliflozin—Urticaria—Phentermine—obesity	0.000715	0.00464	CcSEcCtD
Canagliflozin—Abdominal pain—Phentermine—obesity	0.000712	0.00462	CcSEcCtD
Canagliflozin—Pancreatitis—Orlistat—obesity	0.00071	0.00461	CcSEcCtD
Canagliflozin—Hypersensitivity—Phenylpropanolamine—obesity	0.000693	0.0045	CcSEcCtD
Canagliflozin—ABCC2—endocrine gland—obesity	0.000689	0.0109	CbGeAlD
Canagliflozin—Gastrointestinal disorder—Diethylpropion—obesity	0.000676	0.00439	CcSEcCtD
Canagliflozin—Constipation—Diethylpropion—obesity	0.00067	0.00435	CcSEcCtD
Canagliflozin—Nocturia—Topiramate—obesity	0.000668	0.00434	CcSEcCtD
Canagliflozin—ALB—liver—obesity	0.000663	0.0105	CbGeAlD
Canagliflozin—Dehydration—Bupropion—obesity	0.000657	0.00427	CcSEcCtD
Canagliflozin—Nausea—Phendimetrazine—obesity	0.000654	0.00425	CcSEcCtD
Canagliflozin—Pollakiuria—Sibutramine—obesity	0.000647	0.0042	CcSEcCtD
Canagliflozin—Asthenia—Phentermine—obesity	0.000646	0.00419	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Bupropion—obesity	0.000645	0.00419	CcSEcCtD
Canagliflozin—Fatigue—Cimetidine—obesity	0.000643	0.00417	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Sibutramine—obesity	0.000639	0.00415	CcSEcCtD
Canagliflozin—Breast disorder—Bupropion—obesity	0.000638	0.00414	CcSEcCtD
Canagliflozin—Constipation—Cimetidine—obesity	0.000638	0.00414	CcSEcCtD
Canagliflozin—Urinary tract infection—Orlistat—obesity	0.000627	0.00407	CcSEcCtD
Canagliflozin—Urticaria—Diethylpropion—obesity	0.000622	0.00404	CcSEcCtD
Canagliflozin—Dizziness—Phenylpropanolamine—obesity	0.000622	0.00404	CcSEcCtD
Canagliflozin—ABCC2—liver—obesity	0.000621	0.00981	CbGeAlD
Canagliflozin—Urinary tract infection—Sibutramine—obesity	0.000607	0.00394	CcSEcCtD
Canagliflozin—Cystitis noninfective—Topiramate—obesity	0.000606	0.00393	CcSEcCtD
Canagliflozin—Cystitis—Topiramate—obesity	0.000599	0.00389	CcSEcCtD
Canagliflozin—Pancreatitis—Bupropion—obesity	0.000599	0.00389	CcSEcCtD
Canagliflozin—Dizziness—Phentermine—obesity	0.000596	0.00387	CcSEcCtD
Canagliflozin—Rash—Phenylpropanolamine—obesity	0.000593	0.00385	CcSEcCtD
Canagliflozin—Dermatitis—Phenylpropanolamine—obesity	0.000593	0.00385	CcSEcCtD
Canagliflozin—Vaginal infection—Topiramate—obesity	0.000585	0.0038	CcSEcCtD
Canagliflozin—Urinary tract disorder—Orlistat—obesity	0.000572	0.00371	CcSEcCtD
Canagliflozin—Urethral disorder—Orlistat—obesity	0.000568	0.00369	CcSEcCtD
Canagliflozin—Rash—Phentermine—obesity	0.000568	0.00369	CcSEcCtD
Canagliflozin—Dermatitis—Phentermine—obesity	0.000567	0.00368	CcSEcCtD
Canagliflozin—Pollakiuria—Bupropion—obesity	0.000564	0.00366	CcSEcCtD
Canagliflozin—Rash maculo-papular—Topiramate—obesity	0.000564	0.00366	CcSEcCtD
Canagliflozin—Bladder pain—Topiramate—obesity	0.000561	0.00364	CcSEcCtD
Canagliflozin—Urine output increased—Topiramate—obesity	0.000561	0.00364	CcSEcCtD
Canagliflozin—Nausea—Phenylpropanolamine—obesity	0.000559	0.00363	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Bupropion—obesity	0.000557	0.00362	CcSEcCtD
Canagliflozin—Hypersensitivity—Cimetidine—obesity	0.000549	0.00357	CcSEcCtD
Canagliflozin—Nausea—Phentermine—obesity	0.000535	0.00347	CcSEcCtD
Canagliflozin—Asthenia—Cimetidine—obesity	0.000535	0.00347	CcSEcCtD
Canagliflozin—Urinary tract infection—Bupropion—obesity	0.000529	0.00344	CcSEcCtD
Canagliflozin—Dizziness—Diethylpropion—obesity	0.000518	0.00336	CcSEcCtD
Canagliflozin—Diabetes mellitus—Topiramate—obesity	0.000518	0.00336	CcSEcCtD
Canagliflozin—Polyuria—Topiramate—obesity	0.000513	0.00333	CcSEcCtD
Canagliflozin—Angiopathy—Sibutramine—obesity	0.000509	0.0033	CcSEcCtD
Canagliflozin—Malnutrition—Orlistat—obesity	0.000504	0.00327	CcSEcCtD
Canagliflozin—ABCB1—islet of Langerhans—obesity	0.0005	0.00789	CbGeAlD
Canagliflozin—Rash—Diethylpropion—obesity	0.000494	0.00321	CcSEcCtD
Canagliflozin—Dermatitis—Diethylpropion—obesity	0.000494	0.0032	CcSEcCtD
Canagliflozin—Dizziness—Cimetidine—obesity	0.000493	0.0032	CcSEcCtD
Canagliflozin—Malnutrition—Sibutramine—obesity	0.000488	0.00317	CcSEcCtD
Canagliflozin—Urinary tract disorder—Bupropion—obesity	0.000483	0.00313	CcSEcCtD
Canagliflozin—Urethral disorder—Bupropion—obesity	0.000479	0.00311	CcSEcCtD
Canagliflozin—Thirst—Topiramate—obesity	0.000473	0.00307	CcSEcCtD
Canagliflozin—ABCB1—respiratory system—obesity	0.000472	0.00745	CbGeAlD
Canagliflozin—Rash—Cimetidine—obesity	0.00047	0.00305	CcSEcCtD
Canagliflozin—Dermatitis—Cimetidine—obesity	0.00047	0.00305	CcSEcCtD
Canagliflozin—Nausea—Diethylpropion—obesity	0.000465	0.00302	CcSEcCtD
Canagliflozin—Hypoglycaemia—Topiramate—obesity	0.000461	0.00299	CcSEcCtD
Canagliflozin—Angioedema—Orlistat—obesity	0.000461	0.00299	CcSEcCtD
Canagliflozin—Angioedema—Sibutramine—obesity	0.000446	0.00289	CcSEcCtD
Canagliflozin—Angiopathy—Bupropion—obesity	0.000443	0.00288	CcSEcCtD
Canagliflozin—Nausea—Cimetidine—obesity	0.000443	0.00287	CcSEcCtD
Canagliflozin—Syncope—Sibutramine—obesity	0.000438	0.00284	CcSEcCtD
Canagliflozin—Convulsion—Orlistat—obesity	0.000437	0.00284	CcSEcCtD
Canagliflozin—Loss of consciousness—Sibutramine—obesity	0.000429	0.00278	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000426	0.00277	CcSEcCtD
Canagliflozin—Malnutrition—Bupropion—obesity	0.000425	0.00276	CcSEcCtD
Canagliflozin—CYP3A4—digestive system—obesity	0.000424	0.00669	CbGeAlD
Canagliflozin—Convulsion—Sibutramine—obesity	0.000423	0.00274	CcSEcCtD
Canagliflozin—Blood creatinine increased—Topiramate—obesity	0.000422	0.00274	CcSEcCtD
Canagliflozin—Dry mouth—Orlistat—obesity	0.00042	0.00273	CcSEcCtD
Canagliflozin—Dehydration—Topiramate—obesity	0.000419	0.00272	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Topiramate—obesity	0.000411	0.00267	CcSEcCtD
Canagliflozin—Infection—Orlistat—obesity	0.000409	0.00265	CcSEcCtD
Canagliflozin—Breast disorder—Topiramate—obesity	0.000407	0.00264	CcSEcCtD
Canagliflozin—Dry mouth—Sibutramine—obesity	0.000406	0.00264	CcSEcCtD
Canagliflozin—Nervous system disorder—Orlistat—obesity	0.000404	0.00262	CcSEcCtD
Canagliflozin—Skin disorder—Orlistat—obesity	0.0004	0.0026	CcSEcCtD
Canagliflozin—ABCB1—adrenal cortex—obesity	0.000396	0.00625	CbGeAlD
Canagliflozin—Infection—Sibutramine—obesity	0.000396	0.00257	CcSEcCtD
Canagliflozin—Shock—Sibutramine—obesity	0.000392	0.00254	CcSEcCtD
Canagliflozin—Angioedema—Bupropion—obesity	0.000389	0.00252	CcSEcCtD
Canagliflozin—Skin disorder—Sibutramine—obesity	0.000387	0.00251	CcSEcCtD
Canagliflozin—Syncope—Bupropion—obesity	0.000382	0.00248	CcSEcCtD
Canagliflozin—Pancreatitis—Topiramate—obesity	0.000381	0.00248	CcSEcCtD
Canagliflozin—Loss of consciousness—Bupropion—obesity	0.000374	0.00243	CcSEcCtD
Canagliflozin—Hypotension—Sibutramine—obesity	0.000372	0.00242	CcSEcCtD
Canagliflozin—Convulsion—Bupropion—obesity	0.000369	0.00239	CcSEcCtD
Canagliflozin—ABCB1—cardiovascular system—obesity	0.000361	0.00571	CbGeAlD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00036	0.00234	CcSEcCtD
Canagliflozin—Pollakiuria—Topiramate—obesity	0.000359	0.00233	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Orlistat—obesity	0.000355	0.00231	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Topiramate—obesity	0.000355	0.00231	CcSEcCtD
Canagliflozin—Fatigue—Orlistat—obesity	0.000355	0.0023	CcSEcCtD
Canagliflozin—Dry mouth—Bupropion—obesity	0.000354	0.0023	CcSEcCtD
Canagliflozin—CYP3A4—endocrine gland—obesity	0.00035	0.00553	CbGeAlD
Canagliflozin—Infection—Bupropion—obesity	0.000345	0.00224	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Sibutramine—obesity	0.000344	0.00223	CcSEcCtD
Canagliflozin—Shock—Bupropion—obesity	0.000342	0.00222	CcSEcCtD
Canagliflozin—Constipation—Sibutramine—obesity	0.000341	0.00221	CcSEcCtD
Canagliflozin—Nervous system disorder—Bupropion—obesity	0.000341	0.00221	CcSEcCtD
Canagliflozin—Skin disorder—Bupropion—obesity	0.000337	0.00219	CcSEcCtD
Canagliflozin—Urinary tract infection—Topiramate—obesity	0.000337	0.00219	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Orlistat—obesity	0.000337	0.00218	CcSEcCtD
Canagliflozin—Urticaria—Orlistat—obesity	0.000327	0.00212	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Sibutramine—obesity	0.000326	0.00211	CcSEcCtD
Canagliflozin—Abdominal pain—Orlistat—obesity	0.000325	0.00211	CcSEcCtD
Canagliflozin—Hypotension—Bupropion—obesity	0.000324	0.00211	CcSEcCtD
Canagliflozin—ABCB1—pituitary gland—obesity	0.00032	0.00505	CbGeAlD
Canagliflozin—ABCB1—adipose tissue—obesity	0.000319	0.00503	CbGeAlD
Canagliflozin—Urticaria—Sibutramine—obesity	0.000316	0.00205	CcSEcCtD
Canagliflozin—CYP3A4—liver—obesity	0.000316	0.00499	CbGeAlD
Canagliflozin—Abdominal pain—Sibutramine—obesity	0.000315	0.00204	CcSEcCtD
Canagliflozin—Urinary tract disorder—Topiramate—obesity	0.000308	0.002	CcSEcCtD
Canagliflozin—Urethral disorder—Topiramate—obesity	0.000305	0.00198	CcSEcCtD
Canagliflozin—Hypersensitivity—Orlistat—obesity	0.000303	0.00197	CcSEcCtD
Canagliflozin—ABCB1—digestive system—obesity	0.0003	0.00474	CbGeAlD
Canagliflozin—Gastrointestinal disorder—Bupropion—obesity	0.0003	0.00195	CcSEcCtD
Canagliflozin—Fatigue—Bupropion—obesity	0.000299	0.00194	CcSEcCtD
Canagliflozin—Constipation—Bupropion—obesity	0.000297	0.00193	CcSEcCtD
Canagliflozin—Asthenia—Orlistat—obesity	0.000295	0.00192	CcSEcCtD
Canagliflozin—Hypersensitivity—Sibutramine—obesity	0.000293	0.0019	CcSEcCtD
Canagliflozin—Pruritus—Orlistat—obesity	0.000291	0.00189	CcSEcCtD
Canagliflozin—ABCB1—adrenal gland—obesity	0.000286	0.00451	CbGeAlD
Canagliflozin—Asthenia—Sibutramine—obesity	0.000286	0.00186	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Bupropion—obesity	0.000284	0.00184	CcSEcCtD
Canagliflozin—Angiopathy—Topiramate—obesity	0.000283	0.00183	CcSEcCtD
Canagliflozin—Pruritus—Sibutramine—obesity	0.000282	0.00183	CcSEcCtD
Canagliflozin—Urticaria—Bupropion—obesity	0.000276	0.00179	CcSEcCtD
Canagliflozin—Abdominal pain—Bupropion—obesity	0.000275	0.00178	CcSEcCtD
Canagliflozin—Dizziness—Orlistat—obesity	0.000272	0.00177	CcSEcCtD
Canagliflozin—Malnutrition—Topiramate—obesity	0.000271	0.00176	CcSEcCtD
Canagliflozin—Erythema—Topiramate—obesity	0.000271	0.00176	CcSEcCtD
Canagliflozin—Dizziness—Sibutramine—obesity	0.000263	0.00171	CcSEcCtD
Canagliflozin—Rash—Orlistat—obesity	0.00026	0.00168	CcSEcCtD
Canagliflozin—Dermatitis—Orlistat—obesity	0.000259	0.00168	CcSEcCtD
Canagliflozin—Hypersensitivity—Bupropion—obesity	0.000256	0.00166	CcSEcCtD
Canagliflozin—Rash—Sibutramine—obesity	0.000251	0.00163	CcSEcCtD
Canagliflozin—Dermatitis—Sibutramine—obesity	0.000251	0.00163	CcSEcCtD
Canagliflozin—Asthenia—Bupropion—obesity	0.000249	0.00162	CcSEcCtD
Canagliflozin—ABCB1—endocrine gland—obesity	0.000248	0.00391	CbGeAlD
Canagliflozin—Pruritus—Bupropion—obesity	0.000246	0.00159	CcSEcCtD
Canagliflozin—Nausea—Orlistat—obesity	0.000244	0.00159	CcSEcCtD
Canagliflozin—Syncope—Topiramate—obesity	0.000243	0.00158	CcSEcCtD
Canagliflozin—Loss of consciousness—Topiramate—obesity	0.000238	0.00155	CcSEcCtD
Canagliflozin—Nausea—Sibutramine—obesity	0.000237	0.00154	CcSEcCtD
Canagliflozin—Convulsion—Topiramate—obesity	0.000235	0.00152	CcSEcCtD
Canagliflozin—Dizziness—Bupropion—obesity	0.00023	0.00149	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000229	0.00149	CcSEcCtD
Canagliflozin—Dry mouth—Topiramate—obesity	0.000226	0.00147	CcSEcCtD
Canagliflozin—ABCB1—liver—obesity	0.000223	0.00353	CbGeAlD
Canagliflozin—Infection—Topiramate—obesity	0.00022	0.00143	CcSEcCtD
Canagliflozin—Rash—Bupropion—obesity	0.000219	0.00142	CcSEcCtD
Canagliflozin—Dermatitis—Bupropion—obesity	0.000219	0.00142	CcSEcCtD
Canagliflozin—Shock—Topiramate—obesity	0.000218	0.00141	CcSEcCtD
Canagliflozin—Nervous system disorder—Topiramate—obesity	0.000217	0.00141	CcSEcCtD
Canagliflozin—Skin disorder—Topiramate—obesity	0.000215	0.00139	CcSEcCtD
Canagliflozin—Hypotension—Topiramate—obesity	0.000207	0.00134	CcSEcCtD
Canagliflozin—Nausea—Bupropion—obesity	0.000206	0.00134	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Topiramate—obesity	0.000191	0.00124	CcSEcCtD
Canagliflozin—Fatigue—Topiramate—obesity	0.000191	0.00124	CcSEcCtD
Canagliflozin—Constipation—Topiramate—obesity	0.000189	0.00123	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Topiramate—obesity	0.000181	0.00117	CcSEcCtD
Canagliflozin—Urticaria—Topiramate—obesity	0.000176	0.00114	CcSEcCtD
Canagliflozin—Abdominal pain—Topiramate—obesity	0.000175	0.00114	CcSEcCtD
Canagliflozin—Hypersensitivity—Topiramate—obesity	0.000163	0.00106	CcSEcCtD
Canagliflozin—Asthenia—Topiramate—obesity	0.000159	0.00103	CcSEcCtD
Canagliflozin—Pruritus—Topiramate—obesity	0.000157	0.00102	CcSEcCtD
Canagliflozin—Dizziness—Topiramate—obesity	0.000146	0.00095	CcSEcCtD
Canagliflozin—Rash—Topiramate—obesity	0.000139	0.000905	CcSEcCtD
Canagliflozin—Dermatitis—Topiramate—obesity	0.000139	0.000905	CcSEcCtD
Canagliflozin—Nausea—Topiramate—obesity	0.000131	0.000853	CcSEcCtD
Canagliflozin—ALB—Metabolism—DCN—obesity	8.73e-06	4.51e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ENPP1—obesity	8.73e-06	4.51e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALOX12—obesity	8.73e-06	4.51e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MTHFR—obesity	8.69e-06	4.49e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IGF1—obesity	8.63e-06	4.46e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—AKT2—obesity	8.63e-06	4.46e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—obesity	8.58e-06	4.43e-05	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—PIK3CA—obesity	8.54e-06	4.41e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARA—obesity	8.53e-06	4.4e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CPT1A—obesity	8.5e-06	4.39e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HMGCS1—obesity	8.46e-06	4.37e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	8.41e-06	4.35e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CLOCK—obesity	8.35e-06	4.32e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC22A1—obesity	8.35e-06	4.32e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	8.35e-06	4.31e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NAMPT—obesity	8.33e-06	4.31e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3CD—obesity	8.29e-06	4.28e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARG—obesity	8.28e-06	4.28e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LIPC—obesity	8.28e-06	4.28e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GCK—obesity	8.28e-06	4.28e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AGT—obesity	8.26e-06	4.27e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOC3—obesity	8.23e-06	4.25e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ACADM—obesity	8.21e-06	4.24e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ANGPTL4—obesity	8.21e-06	4.24e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SAT1—obesity	8.21e-06	4.24e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLIN1—obesity	8.21e-06	4.24e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PFKFB3—obesity	8.21e-06	4.24e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PNPLA2—obesity	8.21e-06	4.24e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SERPINE1—obesity	8.2e-06	4.24e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—POMC—obesity	8.17e-06	4.22e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SULT2A1—obesity	8.14e-06	4.21e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GLP1R—obesity	8.14e-06	4.21e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOE—obesity	8.09e-06	4.18e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CAV1—obesity	8.02e-06	4.14e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DPYD—obesity	8.01e-06	4.14e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOA1—obesity	8e-06	4.13e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CETP—obesity	7.99e-06	4.13e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ACACB—obesity	7.99e-06	4.13e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYTB—obesity	7.99e-06	4.13e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—OXCT1—obesity	7.99e-06	4.13e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—RHOA—obesity	7.91e-06	4.09e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SDC1—obesity	7.9e-06	4.08e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	7.83e-06	4.05e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS3—obesity	7.83e-06	4.04e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3R1—obesity	7.83e-06	4.04e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PNLIP—obesity	7.78e-06	4.02e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SRD5A1—obesity	7.78e-06	4.02e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AKR1C3—obesity	7.77e-06	4.02e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PRKAR2B—obesity	7.71e-06	3.98e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.66e-06	3.96e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DCN—obesity	7.65e-06	3.95e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SCARB1—obesity	7.65e-06	3.95e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SDC3—obesity	7.6e-06	3.92e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—obesity	7.55e-06	3.9e-05	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—AKT1—obesity	7.53e-06	3.89e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CPT1A—obesity	7.44e-06	3.85e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SREBF1—obesity	7.43e-06	3.84e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP26B1—obesity	7.42e-06	3.84e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—STS—obesity	7.42e-06	3.84e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HK2—obesity	7.42e-06	3.84e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NAMPT—obesity	7.3e-06	3.77e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CG—obesity	7.3e-06	3.77e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARD—obesity	7.27e-06	3.75e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LIPC—obesity	7.26e-06	3.75e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GCK—obesity	7.26e-06	3.75e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT2—obesity	7.22e-06	3.73e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3CB—obesity	7.22e-06	3.73e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOC3—obesity	7.21e-06	3.73e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—obesity	7.13e-06	3.68e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC27A1—obesity	7.12e-06	3.68e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—FASN—obesity	7.07e-06	3.65e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARG—obesity	7.05e-06	3.64e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—BCHE—obesity	7.04e-06	3.64e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CETP—obesity	7e-06	3.62e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GLUL—obesity	6.98e-06	3.61e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FABP4—obesity	6.98e-06	3.61e-05	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—AKT1—obesity	6.98e-06	3.61e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—POMC—obesity	6.95e-06	3.59e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SDC1—obesity	6.92e-06	3.58e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—INS—obesity	6.91e-06	3.57e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	6.87e-06	3.55e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AKR1C3—obesity	6.81e-06	3.52e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2E1—obesity	6.79e-06	3.51e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NQO1—obesity	6.72e-06	3.47e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SCARB1—obesity	6.7e-06	3.46e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ECHS1—obesity	6.62e-06	3.42e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—UCP2—obesity	6.62e-06	3.42e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HSD11B1—obesity	6.62e-06	3.42e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—UCP3—obesity	6.62e-06	3.42e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	6.58e-06	3.4e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	6.52e-06	3.37e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ADH1B—obesity	6.51e-06	3.36e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SREBF1—obesity	6.51e-06	3.36e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC2A4—obesity	6.44e-06	3.33e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GCG—obesity	6.44e-06	3.33e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CD—obesity	6.42e-06	3.32e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARGC1B—obesity	6.41e-06	3.31e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GPAM—obesity	6.41e-06	3.31e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ACSL1—obesity	6.41e-06	3.31e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYCS—obesity	6.36e-06	3.28e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALB—obesity	6.34e-06	3.27e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT2—obesity	6.33e-06	3.27e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT1—obesity	6.24e-06	3.22e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GGT1—obesity	6.24e-06	3.22e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PCK1—obesity	6.22e-06	3.21e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HADH—obesity	6.22e-06	3.21e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FADS1—obesity	6.22e-06	3.21e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—obesity	6.21e-06	3.21e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—FASN—obesity	6.19e-06	3.2e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—BCHE—obesity	6.17e-06	3.19e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NCOA1—obesity	6.14e-06	3.17e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3R1—obesity	6.06e-06	3.13e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NOS3—obesity	6.06e-06	3.13e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP19A1—obesity	6.05e-06	3.13e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—STK11—obesity	6.05e-06	3.13e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ACP5—obesity	6.05e-06	3.13e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2E1—obesity	5.95e-06	3.08e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—G6PD—obesity	5.9e-06	3.05e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NQO1—obesity	5.88e-06	3.04e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HK1—obesity	5.83e-06	3.01e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SREBF2—obesity	5.83e-06	3.01e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC2A4—obesity	5.64e-06	2.92e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GCG—obesity	5.64e-06	2.92e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—COMT—obesity	5.63e-06	2.91e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LPA—obesity	5.63e-06	2.91e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CB—obesity	5.59e-06	2.89e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYCS—obesity	5.57e-06	2.88e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GNB3—obesity	5.55e-06	2.87e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARGC1A—obesity	5.55e-06	2.87e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS2—obesity	5.54e-06	2.86e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HMOX1—obesity	5.52e-06	2.85e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LPIN1—obesity	5.51e-06	2.85e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GGT1—obesity	5.46e-06	2.82e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT1—obesity	5.46e-06	2.82e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GNAS—obesity	5.4e-06	2.79e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOA5—obesity	5.39e-06	2.79e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NCOA1—obesity	5.38e-06	2.78e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—STK11—obesity	5.3e-06	2.74e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP19A1—obesity	5.3e-06	2.74e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOB—obesity	5.29e-06	2.73e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TGFB1—obesity	5.18e-06	2.67e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC22A1—obesity	5.15e-06	2.66e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CLOCK—obesity	5.15e-06	2.66e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LPL—obesity	5.05e-06	2.61e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GLP1R—obesity	5.01e-06	2.59e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SULT2A1—obesity	5.01e-06	2.59e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DPYD—obesity	4.93e-06	2.55e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—COMT—obesity	4.93e-06	2.55e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GPX1—obesity	4.93e-06	2.55e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARGC1A—obesity	4.86e-06	2.51e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GNB3—obesity	4.86e-06	2.51e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HMOX1—obesity	4.84e-06	2.5e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CD36—obesity	4.8e-06	2.48e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PRKAR2B—obesity	4.75e-06	2.45e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GNAS—obesity	4.73e-06	2.45e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DCN—obesity	4.72e-06	2.44e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOB—obesity	4.64e-06	2.4e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CPT1A—obesity	4.59e-06	2.37e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MTHFR—obesity	4.55e-06	2.35e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NAMPT—obesity	4.5e-06	2.32e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LIPC—obesity	4.47e-06	2.31e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GCK—obesity	4.47e-06	2.31e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARA—obesity	4.46e-06	2.31e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOC3—obesity	4.44e-06	2.3e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LPL—obesity	4.43e-06	2.29e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PIK3CA—obesity	4.4e-06	2.28e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AGT—obesity	4.32e-06	2.23e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GPX1—obesity	4.32e-06	2.23e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CETP—obesity	4.31e-06	2.23e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SDC1—obesity	4.26e-06	2.2e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOE—obesity	4.24e-06	2.19e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CD36—obesity	4.21e-06	2.17e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CAV1—obesity	4.2e-06	2.17e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AKR1C3—obesity	4.2e-06	2.17e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOA1—obesity	4.19e-06	2.16e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SCARB1—obesity	4.13e-06	2.13e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.01e-06	2.07e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SREBF1—obesity	4.01e-06	2.07e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MTHFR—obesity	3.99e-06	2.06e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARA—obesity	3.91e-06	2.02e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT2—obesity	3.9e-06	2.02e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CG—obesity	3.82e-06	1.98e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FASN—obesity	3.82e-06	1.97e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—BCHE—obesity	3.8e-06	1.96e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AGT—obesity	3.79e-06	1.96e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOE—obesity	3.71e-06	1.92e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARG—obesity	3.69e-06	1.91e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CAV1—obesity	3.68e-06	1.9e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOA1—obesity	3.67e-06	1.9e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2E1—obesity	3.67e-06	1.89e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—POMC—obesity	3.64e-06	1.88e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NQO1—obesity	3.63e-06	1.87e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—INS—obesity	3.62e-06	1.87e-05	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—AKT1—obesity	3.6e-06	1.86e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC2A4—obesity	3.48e-06	1.8e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GCG—obesity	3.48e-06	1.8e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYCS—obesity	3.43e-06	1.77e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3CA—obesity	3.41e-06	1.76e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GGT1—obesity	3.37e-06	1.74e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT1—obesity	3.37e-06	1.74e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CD—obesity	3.36e-06	1.74e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CG—obesity	3.35e-06	1.73e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NCOA1—obesity	3.32e-06	1.71e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP19A1—obesity	3.27e-06	1.69e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—STK11—obesity	3.27e-06	1.69e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARG—obesity	3.23e-06	1.67e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—POMC—obesity	3.19e-06	1.65e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NOS3—obesity	3.17e-06	1.64e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3R1—obesity	3.17e-06	1.64e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—INS—obesity	3.17e-06	1.64e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—COMT—obesity	3.04e-06	1.57e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GNB3—obesity	3e-06	1.55e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARGC1A—obesity	3e-06	1.55e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HMOX1—obesity	2.98e-06	1.54e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CD—obesity	2.94e-06	1.52e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CB—obesity	2.93e-06	1.51e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GNAS—obesity	2.92e-06	1.51e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALB—obesity	2.91e-06	1.5e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS2—obesity	2.9e-06	1.5e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOB—obesity	2.86e-06	1.48e-05	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AKT1—obesity	2.79e-06	1.44e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3R1—obesity	2.78e-06	1.44e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NOS3—obesity	2.78e-06	1.44e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LPL—obesity	2.73e-06	1.41e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GPX1—obesity	2.66e-06	1.38e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CD36—obesity	2.59e-06	1.34e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CB—obesity	2.57e-06	1.33e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS2—obesity	2.54e-06	1.31e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MTHFR—obesity	2.46e-06	1.27e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARA—obesity	2.41e-06	1.24e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AGT—obesity	2.33e-06	1.21e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOE—obesity	2.29e-06	1.18e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CAV1—obesity	2.27e-06	1.17e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOA1—obesity	2.26e-06	1.17e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CG—obesity	2.06e-06	1.07e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARG—obesity	1.99e-06	1.03e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—POMC—obesity	1.96e-06	1.01e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—INS—obesity	1.95e-06	1.01e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CD—obesity	1.81e-06	9.37e-06	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALB—obesity	1.79e-06	9.25e-06	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3CA—obesity	1.79e-06	9.23e-06	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3R1—obesity	1.71e-06	8.85e-06	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NOS3—obesity	1.71e-06	8.85e-06	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CB—obesity	1.58e-06	8.17e-06	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS2—obesity	1.57e-06	8.09e-06	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3CA—obesity	1.56e-06	8.08e-06	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AKT1—obesity	1.46e-06	7.54e-06	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AKT1—obesity	1.28e-06	6.6e-06	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3CA—obesity	9.64e-07	4.98e-06	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AKT1—obesity	7.87e-07	4.07e-06	CbGpPWpGaD
